🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Kaltenborn and Mulligan Mobilisation in Patients With Carpal Tunnel Syndrome.

RecruitingNAAges 20 Years - 45 YearsAllRiphah International University
NCT06687018 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Carpal Tunnel Syndrome is the most common mononeuropathy that results from the compression of median nerve in carpal tunnel, leading to entrapment neuropathy. The symptoms become aggravated during drawing, typing or playing video games. The aim of study will be to compare the effects of Kaltenborn and Mulligan mobilisation on pain, disability and hand function in patients with carpal tunnel syndrome.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Both genders between 20 and 45 years of age * Individuals having localized pain, tingling and numbness in the median nerve distribution * Positive Tinel sign and positive Phalen's test Exclusion Criteria: * Any sensory and/or motor deficit in either the ulnar or radial nerve traumatic neck injury * Previous hand surgery or trauma or cervical radiculopathy * Systemic disease e.g. diabetes mellitus or thyroid disease or rheumatoid arthritis
💊

What it tests

  • Kaltenborn mobilisation
  • Mulligan mobilisation
📍

Where

1 site
Ejaz Hospital
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy